Ditropan and Deafness unilateral - a phase IV clinical study of FDA data

Summary:

Deafness unilateral is reported as a side effect among people who take Ditropan (oxybutynin chloride), especially for people who are female, 60+ old, also take Gilenya, and have Relapsing-remitting multiple sclerosis.

The phase IV clinical study analyzes which people have Deafness unilateral when taking Ditropan. It is created by eHealthMe based on reports of 11,571 people who have side effects when taking Ditropan from the FDA, and is updated regularly.

What is Ditropan?

Ditropan has active ingredients of oxybutynin chloride. It is often used in urge incontinence. eHealthMe is studying from 11,799 Ditropan users. Check the latest studies of Ditropan.

What is Deafness unilateral?

Deafness unilateral is found to be associated with 493 drugs and 1,084 conditions by eHealthMe. Check the latest studies of Deafness unilateral.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

11,571 people reported to have side effects when taking Ditropan.
Among them, 11 people (0.1%) have Deafness unilateral.

Could Ditropan cause Deafness unilateral?

Among these 11 people:

What is the gender of people who have Deafness unilateral when taking Ditropan? *

female: 81.82 %
male: 18.18 %

What is the age of people who have Deafness unilateral when taking Ditropan? *

What are other drugs people take besides Ditropan? *

What are other side effects people have besides Deafness unilateral? *

Dizziness: 7 people, 63.64%
Back Pain: 6 people, 54.55%
Head Injury: 5 people, 45.45%
Balance Disorder: 5 people, 45.45%
Pain: 4 people, 36.36%
Migraine (headache): 4 people, 36.36%
Nervousness: 4 people, 36.36%
Numbness And Tingling (unusual prickling sensations): 4 people, 36.36%
Pain In Extremity: 4 people, 36.36%
Lymphopenia (an abnormally low level of lymphocytes in the blood): 4 people, 36.36%

What are the existing conditions these people have? *

Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 5 people, 45.45%
Lhermitte's Sign (an electrical sensation that runs down the back and into the limbs): 4 people, 36.36%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 18.18%
Urinary Tract Infection: 1 person, 9.09%
Stress And Anxiety: 1 person, 9.09%
Pain: 1 person, 9.09%
Nervous System Disorder (a general class of medical conditions affecting the nervous system): 1 person, 9.09%
Asthma: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Ditropan and have Deafness unilateral?

- Check whether Deafness unilateral is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ditropan:

Ditropan (11,799 reports)

Browse all side effects of Ditropan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Deafness unilateral:

Deafness unilateral (493 drugs)

Browse all the conditions that are associated with Deafness unilateral:

Deafness unilateral (1,084 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on oxybutynin chloride (the active ingredients of Ditropan) and Ditropan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.